Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Clinical trial NCT03621670 · COMPLETED
Trial details
- NCT number
- NCT03621670
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-27
- Primary completion
- 2024-12-27
- Enrollment
- 1196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.